Trial intelligence / Profile preview

Enalapril ODMT in young children with heart failure

NCT02652741Phase 3Unknown

Sponsor
Ethicare Clinical Trial Services
Start
Jan 2016
Primary completion
Jun 2017
Countries
5
01

Overview

A Phase 3 trial of enalapril in heart failure (HF), congenital heart disease (CHD), sponsored by Ethicare Clinical Trial Services. Status: unknown.

02

Drugs

enalapril
03

Conditions

heart failure (HF)congenital heart disease (CHD)

Beyond the preview

Go deeper on NCT02652741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02652741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call